KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Treasury Shares (2016 - 2025)

Thermo Fisher Scientific's Treasury Shares history spans 17 years, with the latest figure at $22.3 billion for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares rose 16.04% year-over-year to $22.3 billion, compared with a TTM value of $22.3 billion through Dec 2025, up 16.04%, and an annual FY2025 reading of $22.3 billion, up 16.04% over the prior year.
  • Treasury Shares for Q4 2025 was $68.9 million at Thermo Fisher Scientific, roughly flat from $68.9 million in the prior quarter.
  • The five-year high for Treasury Shares was $68.9 million in Q4 2025, with the low at $44.6 million in Q2 2021.
  • Average Treasury Shares over 5 years is $55.7 million, with a median of $55.5 million recorded in 2023.
  • Year-over-year, Treasury Shares surged 37.61% in 2023 and then increased 16.04% in 2025.
  • Tracing TMO's Treasury Shares over 5 years: stood at $8.9 billion in 2021, then surged by 34.69% to $12.0 billion in 2022, then grew by 25.93% to $15.1 billion in 2023, then grew by 27.05% to $19.2 billion in 2024, then grew by 16.04% to $22.3 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Treasury Shares are $22.3 billion (Q4 2025), $22.3 billion (Q3 2025), and $21.3 billion (Q2 2025).